The CDC on Thursday endorsed Pfizer Covid vaccine booster shots for older teenagers at least six months after they complete their first two Covid-19 doses.
The WHO issued a strong recommendation against administering convalescent plasma to treat Covid patients, citing research that shows no improvement in patients.
The Wall Street Journal is reporting that the FDA is laying the ground work for a quick review of omicron-targeted vaccines and drugs, if needed.
We've learned a lot from the delta wave in the U.S., but health experts say to remain vigilant.
President Joe Biden said he is directing federal agencies to be ready to move quickly to approve vaccines tailored to protect against the Covid omicron variant.
The group will meet Tuesday to vote on whether to recommend that the FDA grant emergency use authorization to the oral antiviral treatment.
The panel's recommendation would open up eligibility to everyone 18 and over, but the group emphasized that everyone 50 and over should get a booster.
The FDA authorized Moderna's and Pfizer's Covid vaccine booster shots for all U.S. adults Friday, after reviewing new data supporting the extra doses.
President Joe Biden said the U.S. has bought 10 million courses of Pfizer's Covid treatment pill Paxlovid and delivery will start at the end of the year.
A monoclonal antibody Covid treatment from Vir Biotechnology and GlaxoSmithKline "stands up well" to all variants of the virus, Vir's president and CEO said.
The White House estimates 2.6 million kids ages 5 to 11, or about 10%, will have gotten their first Covid vaccine shot by Wednesday night.
The pill could help revolutionize the fight against Covid by allowing high-risk people infected with the virus to take an oral antiviral drug at home.
About 900,000 kids ages 5 to 11 have received their first dose of a Covid vaccine since the CDC cleared the shots Nov. 2, the White House said Wednesday.
Dr. Kavita Patel, former White House policy director and fellow at the Brookings Institution, breaks down Pfizer's latest FDA application for its Covid-19 booster.
Philip Morris International met with the FDA on Friday to present its argument for why the tobacco giant should be allowed to import and sell Iqos devices.
"Our booster program is off to a very strong start," Jeff Zients, the White House coronavirus response coordinator, told reporters.
Many parents have questions about the safety and side effects of Covid vaccines for kids ages 5 to 11. These pediatricians and immunologists have answers.
The endorsement was a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
"I think it's going to be liberating for their lives," says the former FDA chief and Pfizer board member.
